ALT
Price
$3.71
Change
+$0.03 (+0.82%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
323.9M
75 days until earnings call
AMRN
Price
$15.45
Change
-$0.02 (-0.13%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
321.41M
Interact to see
Advertisement

ALT vs AMRN

Header iconALT vs AMRN Comparison
Open Charts ALT vs AMRNBanner chart's image
Altimmune
Price$3.71
Change+$0.03 (+0.82%)
Volume$21.99K
Capitalization323.9M
Amarin
Price$15.45
Change-$0.02 (-0.13%)
Volume$294
Capitalization321.41M
ALT vs AMRN Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. AMRN commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Buy and AMRN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (ALT: $3.67 vs. AMRN: $15.47)
Brand notoriety: ALT: Not notable vs. AMRN: Notable
ALT represents the Biotechnology, while AMRN is part of the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALT: 101% vs. AMRN: 45%
Market capitalization -- ALT: $323.9M vs. AMRN: $321.41M
ALT [@Biotechnology] is valued at $323.9M. AMRN’s [@Pharmaceuticals: Major] market capitalization is $321.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $659.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileAMRN’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • AMRN’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRN is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while AMRN’s TA Score has 3 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 3 bearish.
  • AMRN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALT is a better buy in the short-term than AMRN.

Price Growth

ALT (@Biotechnology) experienced а +1.10% price change this week, while AMRN (@Pharmaceuticals: Major) price change was -2.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.28%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +11.94%.

Reported Earning Dates

ALT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Major (-1.28% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($324M) and AMRN($321M) have the same market capitalization . AMRN YTD gains are higher at: 59.485 vs. ALT (-49.098). AMRN has higher annual earnings (EBITDA): -70.12M vs. ALT (-88.03M). AMRN has more cash in the bank: 299M vs. ALT (183M). AMRN has less debt than ALT: AMRN (7.34M) vs ALT (15.8M). AMRN has higher revenues than ALT: AMRN (219M) vs ALT (20K).
ALTAMRNALT / AMRN
Capitalization324M321M101%
EBITDA-88.03M-70.12M126%
Gain YTD-49.09859.485-83%
P/E RatioN/AN/A-
Revenue20K219M0%
Total Cash183M299M61%
Total Debt15.8M7.34M215%
FUNDAMENTALS RATINGS
ALT vs AMRN: Fundamental Ratings
ALT
AMRN
OUTLOOK RATING
1..100
6311
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
9242
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRN's Valuation (89) in the Pharmaceuticals Other industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

AMRN's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

AMRN's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

AMRN's Price Growth Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALT (92) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew somewhat faster than ALT’s over the last 12 months.

AMRN's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTAMRN
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 11 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MHVYF25.620.06
+0.23%
Mitsubishi Heavy Industries Ltd.
KLDCF1.47N/A
+0.01%
Kenorland Minerals Ltd.
BMNM1.23N/A
N/A
Bimini Capital Management, Inc.
IMIAF29.50N/A
N/A
IMI plc
LONKF0.38N/A
N/A
Lonking Holdings, Ltd.